NFKB1 and ovarian carcinoma: Studies have shown that TAK-242 have significant tumoricidal properties against breast cancer and ovarian carcinoma that majorly conferred through the regulation of the activation of NF-κB signaling pathways and expression of the p53-dependent apoptotic genes (305–307).